Company news
Vista Pharmaceuticals Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Vista Pharmaceuticals Ltd. Press Release Aug 14 2026
August 14, 2026
Board Meeting Outcome for Results For The Quarter Ended 30.06.2026
August 14, 2026
Results For The Quarter Ended 30.06.2026
August 14, 2026
Vista Pharmaceuticals Ltd. Press Release Aug 13 2026
August 13, 2026
Board Meeting Intimation for Approval Of Un Audited Financials Results For The Quarter Ended 30.06.2026
August 13, 2026
Vista Pharmaceuticals Ltd. Press Release Jun 25 2026
June 25, 2026
Closure of Trading Window
June 25, 2026
Vista Pharmaceuticals Ltd. Press Release Apr 29 2026
April 29, 2026
Vista Pharmaceuticals Ltd. Press Release Mar 27 2026
March 27, 2026
Closure of Trading Window
March 27, 2026
Vista Pharmaceuticals Ltd. Press Release Feb 13 2026
February 13, 2026
Board Meeting Outcome for Un Audited Financial Results For The Quarter Ended 31.12.2025
February 13, 2026
Results For The Quarter Ended 31.12.2025
February 13, 2026
Vista Pharmaceuticals Ltd. Press Release Feb 05 2026
February 5, 2026
Update on board meeting
February 5, 2026
Board Meeting Intimation for 1. Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2025.2. Limited Review Report Quarter And Nine Months 31.12.2025.3. Any Other Business With The Permission Of The Chair.
February 5, 2026
Vista Pharmaceuticals Ltd. Press Release Feb 03 2026
February 3, 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - 'Joint Venture Partnership Between Pleiades Therapeutics And Vista Pharmaceuticals Ltd'
February 3, 2026
Vista Pharmaceuticals Ltd. Press Release Jan 13 2026
January 13, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
January 13, 2026
Vista Pharmaceuticals Ltd. Press Release Nov 04 2025
November 4, 2025
Board Meeting Intimation for 1. Unaudited Financial Results For The Quarter Ended 30.09.2025.2. Limited Review Report For Quarter Ended 30.09.2025.3. Any Other Business With The Permission Of The Chair.
November 4, 2025
Vista Pharmaceuticals Ltd. Press Release Oct 14 2025
October 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
October 14, 2025
Vista Pharmaceuticals Ltd. Press Release Sep 30 2025
September 30, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
September 30, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGM
September 30, 2025
Vista Pharmaceuticals Ltd. Press Release Sep 25 2025
September 25, 2025
Closure of Trading Window
September 25, 2025
Vista Pharmaceuticals Ltd. Press Release Sep 09 2025
September 9, 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
September 9, 2025
Vista Pharmaceuticals Ltd. Press Release Sep 08 2025
September 8, 2025
Intimation Of Book Closure Regarding 34" Annual General Meeting
September 8, 2025
Reg. 34 (1) Annual Report.
September 8, 2025
34Th Annual General Meeting Of Vista Pharmaceuticals Limited On Tuesday, 30Th September 2025
September 8, 2025
Vista Pharmaceuticals Ltd. Press Release Aug 13 2025
August 13, 2025
Re-Appointment Of Mr. Murali Meraga (DIN: 02537507) As An Managing Director Of The Company
August 13, 2025
Re-Appointment Of Mr. Pavan Sathvik Gilaka (DIN: 09733182) As An Whole Time Director Of The Company
August 13, 2025
Re-Appointment Of Mr. Dhananjaya Alli (DIN: 00610909) As An Whole Time Director Of The Company
August 13, 2025
Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended 30.06.2025
August 13, 2025
Results - Unaudited Financial Results For The Quarter Ended 30.06.2025
August 13, 2025
Vista Pharmaceuticals Ltd. Press Release Aug 06 2025
August 6, 2025
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 30.06.2025
August 6, 2025
Vista Pharmaceuticals Ltd. Press Release Jul 16 2025
July 16, 2025
Outcome Of Circular Resolution Passed By Board Of Directors Of The Company By Circulation On July 16, 2025 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
July 16, 2025
Vista Pharmaceuticals Ltd. Press Release Jul 15 2025
July 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
July 15, 2025
Vista Pharmaceuticals Ltd. Press Release Jun 27 2025
June 27, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements Requirements) Regulations, 2015.
June 27, 2025
Vista Pharmaceuticals Ltd. Press Release Jun 26 2025
June 26, 2025